The use of human embryonic material was controversial and so research into so-called therapeutic cloning was banned in many countries, including several states in the US. But years after the birth of Dolly, Japanese researchers built on Prof Wilmut’s work and found a way of creating cells that behaved in the same way as embryonic stem cells without using cloning, called Induced Pluripotent Stem Cells (IPS).